SCHEMBL23509790

SCHEMBL23509790

c1ccc(-c2c(-c3ccc(N(c4ccc(-c5ccc(N(c6ccc(-c7nc8ccccn8c7-c7ccccc7)cc6)c6ccc(-n7c8ccccc8c8ccccc87)cc6)cc5)cc4)c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)nc3ccccn23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 3/20 0.47
▸ AKT2 P31751 2/20 0.47
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ USP7 Q93009 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ NTRK1 P04629 1/20 0.37
▸ NR1I2 O75469 1/20 0.36
▸ NR1I3 Q14994 1/20 0.36
▸ RAD51 Q06609 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23509744 1.00 AKT1 (0.47) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509743 0.93 AKT1 (0.43) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509791 0.93 AKT1 (0.43) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509724 0.92 AKT1 (0.41) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL9888855 0.92 AKT1 (0.53) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL9888885 0.92 AKT1 (0.53) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509624 0.92 AKT1 (0.42) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509711 0.92 AKT1 (0.42) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509716 0.92 AKT1 (0.42) AKT1AKT2NPC1RAB9AUSP7
SCHEMBL23509625 0.92 AKT1 (0.42) AKT1AKT2NPC1RAB9AUSP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021114801-A1 IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF 广东阿格蕾雅光电材料有限公司 2021-06-17 — — WO disclosed
Send feedback